South Korean pharmaceutical company Green Cross said it is weighing the possible acquisition of Plasma Resources UK, the supplier of blood plasma to the U.K.'s Department of Health. Bio Products Laboratory, a subsidiary of Plasma Resources, manufactures blood plasma-based products using blood from 32 U.S. centers managed by DCI Biologicals.

Full Story:

Related Summaries